Ledger.Open graph →
SEC Form D · filed November 3, 2021

GVB Biopharma

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Manufacturing
Location
LAS VEGAS, NV
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Phillip Swindells · Las Vegas, NVExec · DirectorWilliam Spiegel · Las Vegas, NVExec · DirectorTheodore Swindells · Las Vegas, NVDirectorJack Feldman · Las Vegas, NVExec · DirectorEric Chen · Los Altos, CAExec · DirectorJohn J. D'Agostino · New York, NYExec · DirectorScott Craven Jones · Kenilworth, ILExec · DirectorChester S. Zygmont Iii · San Diego, CADirectorTodd Davis · Newport Beach, CAExec · DirectorDoug Weekes · Newport Beach, CAExec · DirectorBen Mandell · Miami, FLExec · DirectorScott Sherman · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗